Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 15, 2025
Dr. Vince Clinical Research (DVCR) announced the expansion of its research campus by constructing a new 5,000-square-foot administration building in Overland Park, Kansas.
read more
From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.
read more
DrugDev and Citeline, part of Informa’s Pharma Intelligence vertical, announced the two companies integrated data from Citeline’s Trialtrove and Sitetrove intelligence platforms with the DrugDev Spark unified clinical operations suite.
read more
DSG, Inc., a provider of eClinical technology solutions, data management, professional services and customer support recently opened a new office in Bangalore, India, to accommodate rapid growth and better serve client needs.
read more
Wednesday, November 06, 2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with Opthea Pty Ltd of Melbourne, Australia.
read more
Thursday, October 31, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, today announced it has signed an agreement with the Sanquin Blood Supply Foundation (Sanquin) for the commercial manufacture of a monoclonal antibody used for the recovery and ...
read more
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in June 2013.
read more
DSM, a global leader in materials science and regenerative medicine, announced today the launch of its cellular therapy development services. Cellular therapies use a patient’s own cells to improve healing of an injury or disease. DSM develops ...
read more
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE/Euronext: DSM KON), today announced the signing of a 3 year master supply agreement with Eisai Inc., based in Woodcliff Lake, NJ,...
read more
DSP Clinical has announced a new co-monitoring service that provides flexible monitoring support to help clinical trials meet study timelines.
read more
DSP Clinical has announced a new co-monitoring service that provides flexible, cost-effective monitoring support to help clinical trials meet study timelines.
read more
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, today announced the award of a US$3.3 million contract from the US Defense Threat Reduction Agency (DTRA) to develop biodefence vaccine adjuvants using the company’s ...
read more
Tuesday, October 27, 2020
A Dublin-based tech start-up today announced the launch of Wirano, a digital platform for the rapid organization of clinical trials.
read more
Duchesnay, a specialty pharma company with a long-standing commitment to women's health, has acquired exclusive U.S. and Canadian rights to market and distribute Osphena® (ospemifene) from Shionogi Inc. Osphena® is the only oral, non-hormonal ...
read more
Monday, December 19, 2016
DuPont Industrial Biosciences today announced receipt of a grant from the Bill & Melinda Gates Foundation to support a new area of research. The research project, which commences immediately, aims to create new production systems to enable affordable...
read more